Objective This study aimed to investigate whether artificial intelligence could identify pancreatic ductal adenocarcinoma (PDAC) in patients aged <70 years using only routine laboratory tests (RLTs) applicable to regular health checkups.
Koiwai et al. (2026) studied this question.